Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	34.1	32.4	12.59	36.83	45
Short-Term Investments	73.53	50.57	107.92	-	-
Cash & Short-Term Investments	107.62	82.97	120.51	36.83	45
Cash Growth	29.71%	-31.15%	227.21%	-18.16%	-21.48%
Other Receivables	0.53	0.49	-	-	-
Receivables	0.53	0.49	-	-	-
Prepaid Expenses	0.94	3.62	0.8	0.89	1
Other Current Assets	0.34	0.47	1.31	0.24	0.27
Total Current Assets	109.43	87.55	122.62	37.96	46.27
Property, Plant & Equipment	1.23	1.56	0.19	0.18	0.33
Other Long-Term Assets	0.24	0.3	0.21	0.33	0.53
Total Assets	110.9	89.4	123.02	38.48	47.13
Accounts Payable	3.41	1.81	2.86	2.85	2.02
Accrued Expenses	6.81	3.71	3.52	3.81	3.43
Current Portion of Long-Term Debt	-	-	7	5.95	-
Current Portion of Leases	0.29	0.31	0.03	0.12	0.11
Total Current Liabilities	10.51	5.82	13.4	12.72	5.56
Long-Term Debt	-	-	2.15	8.65	13.95
Long-Term Leases	0.75	1.03	0	0.02	0.14
Other Long-Term Liabilities	-	-	0	-	0.2
Total Liabilities	11.26	6.86	15.56	21.4	19.85
Common Stock	0.09	0.07	0.06	0.03	0.02
Additional Paid-In Capital	386.53	321.64	317.59	197.96	174.24
Retained Earnings	-287.05	-239.13	-210.07	-180.92	-146.98
Comprehensive Income & Other	0.06	-0.03	-0.12	-	-
Total Common Equity	99.64	82.55	107.46	17.08	27.28
Shareholders' Equity	99.64	82.55	107.46	17.08	27.28
Total Liabilities & Equity	110.9	89.4	123.02	38.48	47.13
Total Debt	1.03	1.34	9.18	14.74	14.21
Net Cash (Debt)	106.59	81.63	111.33	22.09	30.79
Net Cash Growth	30.57%	-26.68%	404.06%	-28.27%	-45.94%
Net Cash Per Share	1.05	0.82	1.72	0.97	1.70
Filing Date Shares Outstanding	96.68	68.96	60.05	30.81	19.91
Total Common Shares Outstanding	93.6	68.28	59.94	28.51	18.55
Working Capital	98.92	81.72	109.22	25.23	40.71
Book Value Per Share	1.06	1.21	1.79	0.60	1.47
Tangible Book Value	99.64	82.55	107.46	17.08	27.28
Tangible Book Value Per Share	1.06	1.21	1.79	0.60	1.47
Machinery	0.35	0.3	0.21	0.11	0.11
Construction In Progress	0.01	0.02	0.05	-	-
Leasehold Improvements	0.03	0.03	0.13	0.13	0.13

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q